米国女性の健康診断市場 – 業界動向と2030年までの予測

女性の健康診断市場の分析と規模

女性の健康は、主に女性の健康に影響を与える病気や症状の治療と診断に焦点を当てた医学の分野です。女性の健康診断方法には、乳がん、卵巣がん、子宮頸がん、更年期障害、妊娠など、いくつかの女性関連疾患のスクリーニング、検査、または診断、およびモニタリングが含まれます。女性の健康関連疾患の診断には、さまざまな種類の検査が利用できます。生検装置、画像およびモニタリング システム、マンモグラフィー システムなどの医療診断装置は、がんを検出し、閉塞を取り除き、内臓の画像をキャプチャして、疾患のスクリーニングと診断に役立ちます。診断テストには、乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニングとキャリア テスト、妊娠、排卵検査、卵巣がん検査が含まれます。さまざまな疾患のスクリーニングと検出のためのテストの使用は、合併症を防ぎ、生活の質を向上させるために必要です。健康検査は、健康を改善し、深刻な病気を予防および治療するために不可欠です。                                

データブリッジマーケットリサーチは、2023年に59億6,200万米ドルであった女性の健康診断市場は、2030年までに114億6,200万米ドルに急増し、予測期間中に8.5％のCAGRを達成すると予測しています。これは、市場価値を示しています。「イメージングおよびモニタリングシステム」は、慢性疾患および生活習慣病の発生率の増加により、女性の健康診断市場の診断装置セグメントを支配しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジマーケットリサーチがまとめた市場レポートには、詳細な専門家の分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

女性の健康診断市場の範囲とセグメンテーション

​​​​​​​​

市場の定義

米国の女性の健康診断市場とは、女性の健康状態の評価と監視に特化した医療診断テストとデバイスの開発、製造、流通に重点を置くヘルスケア業界セグメントを指します。これらの診断テストとデバイスは、生殖健康問題、婦人科疾患、乳がん、子宮頸がん、更年期障害、その他の女性特有の健康問題など、主に女性に影響を与えるさまざまな疾患や症状を検出、診断、管理するために医療専門家によって使用されています。

女性の健康診断市場の動向

ドライバー

• 女性の健康に対する意識と関心を高める

女性の健康問題に対する一般の認識と認識が大幅に高まり、診断テストとスクリーニングの需要が高まっています。政府の取り組み、擁護キャンペーン、教育活動は、女性の健康状態の早期発見と予防の重要性を強調する上で重要な役割を果たしてきました。これが今度は市場の成長への道を切り開きました。

• 予防医療への移行

定期的な検査や病気の早期発見など、予防医療の重要性が高まっています。女性の健康診断により、リスク要因を早期に特定できるため、医療従事者は予防措置や個別の治療計画を実施できます。この予防への重点が市場の成長に貢献しています。

• 研究開発活動の強化

女性の健康診断の分野における継続的な研究開発の取り組みにより、革新的な技術、検査、デバイスが導入されています。これにより、利用可能な診断オプションの範囲が拡大し、その精度、信頼性、アクセス性が向上し、市場の成長が促進されます。  

機会

• 診断技術の進歩

Rapid advancements in medical technologies, such as molecular diagnostics, next-generation sequencing, imaging modalities, and point-of-care testing, have revolutionized the field of women's health diagnostics. These innovations have led to more accurate, sensitive, and efficient diagnostic tools, enabling early detection, personalized treatment strategies, and improved patient outcomes. Thus, advancements in diagnostic technologies is expected to act as an opportunity for the growth of market.

Restraints/Challenges

• High cost of diagnostics procedure

The cost of diagnostic tests and devices can be a barrier to access for certain segments of the population. High costs may limit the adoption of advanced diagnostic technologies and screening programs, particularly among uninsured or underinsured individuals. Addressing affordability concerns is crucial to ensure equitable access to women's health diagnostics. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, heavy custom duty imposed on the medical devices, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

This women’s health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In April 2023, Quest Diagnostics and NewYork-Presbyterian, announced that Quest hadcompleted its previously announced acquisition of select assets of the laboratory services business of NewYork-Presbyterian. The goal of the collaboration is to enable providers and patients to access high quality, affordable testing from a service menu that combines the complementary strengths of both organizations
• In March 2023, F. Hoffmann-La Roche Ltd announced that it had entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). The EAPP is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease

U.S. Women’s Health Diagnostics Market Scope

The women’s health diagnostics market is segmented on the basis of diagnostic devices, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnostic Devices

• Imaging and Monitoring Systems
• Biopsy Devices
• Reagents and Kits
• Biomarkers
• Others

Application

• Osteoporosis Testing
• OVC Testing
• Cervical Cancer Testing
• Breast Cancer Testing
• Pregnancy and Fertility Testing
• Prenatal Genetic Screening and Carrier Testing
• Infectious Disease Testing
• STD Testing
• Ultrasound Tests

End User

• Hospitals
• Diagnostic and Imaging Centres
• Clinics and Home Care Setting

Women’s Health Diagnostics Market Regional Analysis/Insights

The women’s health diagnostics market is analyzed and market size insights and trends are provided by country, diagnostic devices, application, and end user as referenced above.

The countries covered in the women’s health diagnostics market report is U.S.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The women’s health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for women’s health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the women’s health diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Women’s health diagnostics Market Share Analysis

The women’s health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to women’s health diagnostics market.

Some of the major players operating in the women’s health diagnostics market are:

• bioMérieux SA
• Carestream Health
• MEDGYN PRODUCTS, INC.
• COOK
• Cardinal Health
• PerkinElmer Inc.
• GENERAL ELECTRIC
• Quest Diagnostics Incorporated
• Sysmex Corporation
• Siemens
• Hologic Inc.
• Abbott
• BD
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Koninklijke Philips N.V.
• NeuroLogica Corp.
• Danaher
• FUJIFILM Holdings Corporation
• Hitachi, Ltd.
• Canon Inc.

SKU-44685